India Hetero gets permission for COVID-19 favipiravir
Hetero Labs Ltd of India obtained regulatory approval to sell its edition of the antiviral drug favipiravir to treat COVID-19, the drug manufacturer said Wednesday, while coronavirus infections in the world’s third-most affected country exceeded 1.5 million.
India Hetero gets permission for COVID-19 favipiravir Read More »